Your session is about to expire
← Back to Search
School-Based Interventions for Anxiety in Autism
Study Summary
This trial will compare two school-based interventions for reducing anxiety in autistic students aged 8-14. It will measure effectiveness, feasibility, and satisfaction of both programs.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Can adults of 20 years and above participate in this research?
"The target demographic for this study are children aged between 7 and 15."
Who is eligible to take part in the experiment?
"Those with autism spectrum disorder, between the ages of 7 and 15, are encouraged to apply for this clinical trial. Up to 200 applicants will be selected for participation."
Are subjects currently being accepted for this investigation?
"Clinicaltrials.gov states that this clinical study is actively seeking participants; it was initially listed on August 25th 2023 and last updated November 28th of the same year."
How many individuals are allowed to take part in this research endeavor?
"Indeed, the clinicaltrials.gov website shows that this research trial is currently searching for participants to enroll in their study. The initial posting was on August 25th 2023 and it was most recently updated on November 28th of that same year. 200 patients are sought after from 1 specific medical centre."
What desired outcome is this trial attempting to achieve?
"The primary assessment of this intervention's efficacy is a Change from Baseline in child-reported anxiety on the Screening for Childhood Anxiety and Related Emotional Disorders (SCARED) scale. Secondary outcomes include Change from Baseline scores on the Emotion Dysregulation Inventory (EDI) and School Anxiety Scale - Teacher Report (SAS-TR), which are 5 point Likert scales that measure emotion regulation, reactivity, and anxiety respectively. These assessments will take place at baseline; 4 weeks after completion of treatment; and 6 months post-intervention."
Share this study with friends
Copy Link
Messenger